Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.

PloS one - 1 Jan 2017

Shou Li-Hong, Cao Dan, Dong Xiao-Hui, Fang Qiu, Wu Ying, Zhang Yan, Fei Ju-Ping, Xu Bao-Lian

Abstract excerpt

OBJECTIVES: This meta-analysis investigates the prognostic effect of SET binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic neutrophilic leukemia (CNL). METHODS: Eligible studies from Pubmed, Embase, and Web of Science were searched from database inception through April 2016. Hazard ratios (HRs) and 95% confidence interval (CI)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to SET gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to SETBP1 gene

Share to Leukemia, Myelomonocytic, Chronic

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Nuclear Proteins

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 28158286
DOI: 10.1371/journal.pone.0171608
PMCID: PMC5291491

Genes

SETBP1
SET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.PMID 28158286Read ↗

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.Semantic proximity Read ↗

SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndromeSemantic proximity Read ↗

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemiaSemantic proximity Read ↗

Mutations in chronic myelomonocytic leukemia and their prognostic relevance.Semantic proximity Read ↗

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patientsSemantic proximity Read ↗

Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.Semantic proximity Read ↗

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.Semantic proximity Read ↗

SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.Semantic proximity Read ↗

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.Semantic proximity Read ↗

Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read ↗

Mutant- <i>SETBP1</i> activates transcription of Myc programs to accelerate <i>CSF3R</i> -driven myeloproliferative neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.